The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo
- PMID: 11139479
- DOI: 10.1161/01.res.88.1.88
The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo
Abstract
Mitogen-activated protein kinase (MAPK) signaling pathways are important regulators of cell growth, proliferation, and stress responsiveness. A family of dual-specificity MAP kinase phosphatases (MKPs) act as critical counteracting factors that directly regulate the magnitude and duration of p38, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase (ERK) activation. Here we show that constitutive expression of MKP-1 in cultured primary cardiomyocytes using adenovirus-mediated gene transfer blocked the activation of p38, JNK1/2, and ERK1/2 and prevented agonist-induced hypertrophy. Transgenic mice expressing physiological levels of MKP-1 in the heart showed (1) no activation of p38, JNK1/2, or ERK1/2; (2) diminished developmental myocardial growth; and (3) attenuated hypertrophy in response to aortic banding and catecholamine infusion. These results provide further evidence implicating MAPK signaling factors as obligate regulators of cardiac growth and hypertrophy and demonstrate the importance of dual-specificity phosphatases as counterbalancing regulatory factors in the heart.
Similar articles
-
Calcineurin enhances MAPK phosphatase-1 expression and p38 MAPK inactivation in cardiac myocytes.J Biol Chem. 2001 May 11;276(19):15913-9. doi: 10.1074/jbc.M100452200. Epub 2001 Feb 22. J Biol Chem. 2001. PMID: 11279073
-
Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy.J Clin Invest. 1998 Oct 1;102(7):1311-20. doi: 10.1172/JCI3512. J Clin Invest. 1998. PMID: 9769323 Free PMC article.
-
Mitogen-activated protein kinase phosphatase 1 inhibits the stimulation of gene expression by hypertrophic agonists in cardiac myocytes.Biochem J. 1997 Apr 15;323 ( Pt 2)(Pt 2):313-9. doi: 10.1042/bj3230313. Biochem J. 1997. PMID: 9163318 Free PMC article.
-
Mitogen-activated protein kinase (MAPK) in cardiac tissues.Mol Cell Biochem. 1996 Apr 12-26;157(1-2):49-57. doi: 10.1007/BF00227880. Mol Cell Biochem. 1996. PMID: 8739228 Review.
-
Protein phosphatases and the regulation of MAP kinase activity.Semin Cell Dev Biol. 1998 Apr;9(2):143-52. doi: 10.1006/scdb.1997.0219. Semin Cell Dev Biol. 1998. PMID: 9599409 Review.
Cited by
-
MAPK phosphatase 1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution.J Clin Invest. 2024 Mar 21;134(10):e172826. doi: 10.1172/JCI172826. J Clin Invest. 2024. PMID: 38512415 Free PMC article.
-
MAP Kinase Phosphatase-5 Deficiency Protects Against Pressure Overload-Induced Cardiac Fibrosis.Front Immunol. 2021 Dec 21;12:790511. doi: 10.3389/fimmu.2021.790511. eCollection 2021. Front Immunol. 2021. PMID: 34992607 Free PMC article.
-
Sleeve Gastrectomy Ameliorates Diabetes-Induced Cardiac Hypertrophy Correlates With the MAPK Signaling Pathway.Front Physiol. 2021 Nov 11;12:785799. doi: 10.3389/fphys.2021.785799. eCollection 2021. Front Physiol. 2021. PMID: 34858216 Free PMC article.
-
ERK1/2: An Integrator of Signals That Alters Cardiac Homeostasis and Growth.Biology (Basel). 2021 Apr 20;10(4):346. doi: 10.3390/biology10040346. Biology (Basel). 2021. PMID: 33923899 Free PMC article. Review.
-
Dual-Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1.J Am Heart Assoc. 2021 Feb 16;10(4):e014311. doi: 10.1161/JAHA.119.014311. Epub 2021 Jan 30. J Am Heart Assoc. 2021. PMID: 33522247 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous